A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma.
Jeremy P HarrisJino ParkEric KuSteven SeyedinRussell StitzleinAmanda GoldinWen-Pin ChenChristine McLarenAllen M ChenWarren ChowPublished in: Cancer control : journal of the Moffitt Cancer Center (2024)
The ultimate goal of combination therapy is improved overall response, including tumors not treated with SBRT. This trial can be found registered online: NCT05488366.
Keyphrases
- combination therapy
- radiation therapy
- squamous cell carcinoma
- small cell lung cancer
- early stage
- study protocol
- locally advanced
- phase iii
- clinical trial
- social media
- brain metastases
- radiation induced
- phase ii
- health information
- advanced non small cell lung cancer
- randomized controlled trial
- healthcare
- newly diagnosed
- open label